Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.967 | 483 | 0 | 1997 | 2020 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.100 | None | 0.977 | 347 | 0 | 1996 | 2020 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 0.989 | 283 | 0 | 2000 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.992 | 259 | 0 | 2000 | 2020 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 0.991 | 218 | 0 | 1984 | 2020 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
phenotype | 0.100 | None | 0.993 | 152 | 0 | 1995 | 2019 | ||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
phenotype | 0.100 | None | 0.867 | 143 | 0 | 1995 | 2019 | |||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
phenotype | 0.100 | None | 0.993 | 142 | 0 | 1999 | 2019 | |||||||||
|
MT-CO2 pseudogene 12 | 0.368 | 0.962 |
|
phenotype | 0.100 | None | 0.993 | 134 | 0 | 1999 | 2019 | |||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
phenotype | 0.100 | None | 0.970 | 133 | 0 | 1992 | 2020 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
phenotype | 0.100 | None | 0.968 | 125 | 0 | 1997 | 2020 | ||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
phenotype | 0.100 | None | 0.991 | 107 | 0 | 2006 | 2019 | |||||||||
|
Yes associated protein 1 | 0.432 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 0.990 | 98 | 0 | 2007 | 2020 | ||||||||
|
GA binding protein transcription factor subunit alpha | 0.379 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.979 | 97 | 0 | 2005 | 2020 | ||||||||
|
SMAD family member 4 | 0.401 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 0.989 | 94 | 0 | 1996 | 2020 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
phenotype | 0.100 | None | 0.989 | 91 | 0 | 1994 | 2020 | ||||||||
|
sirtuin 1 | 0.378 | 0.885 | 8.7E-02 |
|
phenotype | 0.100 | None | 1.000 | 90 | 0 | 2005 | 2020 | ||||||||
|
menin 1 | 0.444 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 0.922 | 90 | 0 | 1991 | 2020 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
phenotype | 0.100 | None | 0.977 | 87 | 0 | 1990 | 2019 | ||||||||
|
fragile histidine triad diadenosine triphosphatase | 0.444 | 0.846 | 5.7E-03 |
|
phenotype | 0.100 | None | 0.947 | 76 | 0 | 1996 | 2019 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 71 | 0 | 2001 | 2020 | ||||||||
|
insulin like growth factor 2 | 0.390 | 0.885 | 4.4E-02 |
|
phenotype | 0.100 | None | 0.943 | 70 | 0 | 1992 | 2019 | ||||||||
|
RUNX family transcription factor 3 | 0.459 | 0.731 | 0.84 |
|
phenotype | 0.100 | None | 0.986 | 70 | 0 | 2002 | 2020 | ||||||||
|
SRY-box transcription factor 2 | 0.405 | 0.808 | 0.71 |
|
phenotype | 0.100 | None | 1.000 | 69 | 0 | 2006 | 2020 | ||||||||
|
Ras association domain family member 1 | 0.420 | 0.808 | 4.9E-06 |
|
phenotype | 0.100 | None | 0.970 | 67 | 0 | 2001 | 2019 |